The prevalence rates of systemic lupus erythematosus (SLE) may vary wi
thin 17-48/100000 population worldwide. Although population-based epid
emiological studies are still missing, the cutaneous variants of lupus
erythematosus (LE) are 2-3 times more frequent than SLE itself. The m
ost common age of onset is 20-40 y. Overall, cutaneous LE is regarded
as a variant with less severe course and better prognosis. However, CD
LE and SCLE last for many years and may lead, like SLE, to severe disa
bility for work and limited life quality; also, a small proportion of
patients with cutaneous LE develops SLE during the course of their dis
ease. This implies considerable amount of medical management and costs
for the community. Early recognition of cutaneous LE patients at risk
to develop SLE and preventive measures against disease triggering fac
tors are important tasks for physicians attending with cutaneous LE pa
tients. It seems that signs of nephropathy, elevated ANA-titers and ar
thralgias may serve as prognostic predictors for transition into SLE.
Characteristic features of cutaneous LE are photosensitivity and femal
e predominance. UV light is a major environmental triggering factor in
cutaneous LE. Skin lesions may be induced or preexistent lesions may
exacerbate due to UV light in up to 80-90% of all patients. Therefore,
socioeconomic counseling of the young patients, for example choice of
occupation and sun protection, are essentials in compliant patients.
Also, since females are 3-6 times more frequently affected than males,
the possibility of hormonal influences including pregnancy and estrog
en-containing drugs should be discussed. Risk considerations for femal
es wishing to become pregnant are required, and avoidance of estrogen-
containing contraceptives should be recommended.